GlassScriptPhysician profile
Renuka Jain
NPI 1811037161
$130,630.44
in general payments reported to CMS, 2019-2025
12 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $6,030 · 2021: $1,817 · 2022: $19K · 2023: $39K · 2024: $36K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Consulting Fee: $24K · Travel and Lodging: $20K · Food and Beverage: $6,400 · Honoraria: $1,925 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,737.50 |
| Consulting Fee | $24,421.89 |
| Travel and Lodging | $20,313.53 |
| Food and Beverage | $6,399.55 |
| Honoraria | $1,925.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $104,112.64 | 2021-2025 | Corevalve Evolut R, Avalus, Apollotm |
| Medtronic Vascular, INC. | $16,106.34 | 2019-2020 | |
| Abbott Laboratories | $3,132.73 | 2019-2024 | Mitraclip |
| Edwards Lifesciences Corporation | $2,397.93 | 2021-2025 | |
| Ancora Heart, INC. | $2,208.78 | 2023 | Accucinch |
| Philips North America LLC | $1,953.85 | 2023-2024 | (1667) Ultrasound Options and Upgrades |
| Boston Scientific Corporation | $278.59 | 2019-2023 | Watchman Access System, Watchman Flx |
| Siemens Medical Solutions USA, INC. | $137.38 | 2025 | |
| Heartflow, INC. | $136.02 | 2019 | |
| Ge Healthcare | $111.58 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $41.68 | 2023-2024 | Flumist Quadrivalent |
| Neos Therapeutics, LP | $12.92 | 2023 | Cotempla Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renuka Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.